Skip to main content
Fig. 3 | Health and Quality of Life Outcomes

Fig. 3

From: Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias

Fig. 3

Response frequencies at week 2 (start of treatment) and end of treatment by treatment arm from the mSICT concerns domains, a Swallowing enough medication, b Medication limiting usual activities, c Feeling upset about side effects. Numbers indicate the number of patients in each response category; *n < 5 patients. DT, dispersible tablet; FCT, film-coated tablet; mSICT, modified Satisfaction with Iron Chelation Therapy

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us